Market Cap 845.13M
Revenue (ttm) 203.07M
Net Income (ttm) -54.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.01%
Debt to Equity Ratio -7.84
Volume 2,963,800
Avg Vol 2,935,140
Day's Range N/A - N/A
Shares Out 153.94M
Stochastic %K 11%
Beta 2.32
Analysts Strong Sell
Price Target $6.25

Latest News on XERS

Xeris Announces Changes to Its Board of Directors

Mar 28, 2025, 8:00 AM EDT - 5 days ago

Xeris Announces Changes to Its Board of Directors


Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Feb 24, 2025, 8:00 AM EST - 5 weeks ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer


Xeris to Participate in Upcoming Investor Conferences

Feb 5, 2025, 8:00 AM EST - 2 months ago

Xeris to Participate in Upcoming Investor Conferences


Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Jan 10, 2025, 7:00 AM EST - 2 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance


Xeris Biopharma Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 7:00 AM EST - 5 months ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results


Xeris Biopharma: Time For A Reassessment

Oct 9, 2024, 11:33 AM EDT - 6 months ago

Xeris Biopharma: Time For A Reassessment


Xeris Biopharma Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 7:00 AM EDT - 8 months ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results


Xeris Biopharma Announces CEO Succession Plan

Jul 8, 2024, 7:00 AM EDT - 9 months ago

Xeris Biopharma Announces CEO Succession Plan


Xeris to Participate in the Jefferies Global Healthcare Conference

May 30, 2024, 7:00 AM EDT - 10 months ago

Xeris to Participate in the Jefferies Global Healthcare Conference


Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Mar 30, 2024, 1:28 AM EDT - 1 year ago

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'


Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 12:43 PM EST - 1 year ago

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript


Xeris Biopharma Updates Its Outlook for 2023

Jan 4, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma Updates Its Outlook for 2023


Xeris Biopharma Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 7:00 AM EST - 1 year ago

Xeris Biopharma Reports Third Quarter 2023 Financial Results


Xeris Biopharma Holdings: On Track To Be Cash Flow Positive

Sep 14, 2023, 9:41 PM EDT - 1 year ago

Xeris Biopharma Holdings: On Track To Be Cash Flow Positive


Xeris Biopharma's Financial Pathway: Growth Amid Challenges

Aug 27, 2023, 1:30 AM EDT - 1 year ago

Xeris Biopharma's Financial Pathway: Growth Amid Challenges